Praxis Precision Medicines, Inc.
The Field Reimbursement Manager (FRM) is a critical field-based role responsible for removing access and reimbursement barriers so patients can start and stay on therapy without unnecessary delay. The FRM partners directly with healthcare providers, specialty pharmacies, hospital systems, and internal stakeholders to navigate complex payer environments and deliver a seamless patient access experience.
Praxis Precision Medicines is a fully integrated, leading CNS precision neuroscience biopharmaceutical company that translates insights from genetic epilepsies into therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The company advances a diversified pipeline across epilepsy and movement disorders using two proprietary platforms: Cerebrum™ (small molecules) and Solidus™ (antisense oligonucleotides). Guided by its DARE FOR MORE® philosophy, Praxis applies human genetics, translational science, and patient-guided development to deliver precision therapies for patients with complex brain disorders.
Praxis Precision Medicines, Inc. (PRAX) Gains Analyst Confidence With Ulixacaltamide
3 weeks ago
Biotech Praxis gives 2,931 stock units to 14 new employees
1 week ago
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 week ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Praxis Precision Medicines, Inc..
Right around the average for this role
3,826 Shares in Praxis Precision Medicines, Inc. $PRAX Purchased by ProShare Advisors LLC
2 weeks ago